IDSA GUIDELINES Bundle (free trial)

IDSA Vertebral Osteomyelitis

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/555263

Contents of this Issue

Navigation

Page 10 of 11

Table 3. Strength of Recommendation and Quality of Evidence Strength of Recommendation/ Quality of Evidence Clarity of Balance Between Desirable and Undesirable Effects Methodological Quality of Supporting Evidence (examples) Implications S/H Desirable effects clearly outweigh undesirable effects, or vice versa Consistent evidence from well-performed RCTs or exceptionally strong evidence from unbiased observational studies Recommendation can apply to most patients in most circumstances. Further research is unlikely to change our confidence in the estimate of effect S/M Desirable effects clearly outweigh undesirable effects, or vice versa Evidence from RCTs with important limitations (inconsistent results, methodological flaws, indirect, or imprecise) or exceptionally strong evidence from unbiased observational studies Recommendation can apply to most patients in most circumstances. Further research (if performed) is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. S/L Desirable effects clearly outweigh undesirable effects, or vice versa Evidence for at least one critical outcome from observational studies, RCTs with serious flaws or indirect evidence Recommendation may change when higher quality evidence becomes available. Further research (if performed) is likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate S/VL (very rarely applicable) Desirable effects clearly outweigh undesirable effects, or vice versa Evidence for at least one critical outcome from unsystematic clinical observations or very indirect evidence Recommendation may change when higher quality evidence becomes available; any estimate of effect for at least one critical outcome is very uncertain. W/H Desirable effects closely balanced with undesirable effects Consistent evidence from well- performed RCTs or exceptionally strong evidence from unbiased observational studies e best action may differ depending on circumstances or patients or societal values. Further research is unlikely to change our confidence in the estimate of effect. W/M Desirable effects closely balanced with undesirable effects Evidence from RCTs with important limitations (inconsistent results, methodological flaws, indirect, or imprecise) or exceptionally strong evidence from unbiased observational studies Alternative approaches likely to be better for some patients under some circumstances. Further research (if performed) is likely to have an important impact on our confidence in the estimate of effect and may change the estimate

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - IDSA Vertebral Osteomyelitis